Le Lézard
Classified in: Covid-19 virus
Subjects: CCA, MAT

Canopy Rivers Announces AGM Date


TORONTO, Aug. 18, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 24, 2020 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company's profile on the System for Electronic Document Analysis and Retrieval or on its website at www.canopyrivers.com/investors.

The Meeting will be held at the offices of the Company. However, due to health concerns relating to the novel coronavirus pandemic and to comply with government and public health directives, the Company is urging all Shareholders to vote by proxy in advance of the Meeting and is discouraging physical attendance in person at the Meeting. The Meeting will not be open to the general public and will be limited to registered Shareholders and duly appointed proxyholders only. Shareholders who wish to access and ask questions at the Meeting can do so by phone or audio-only webcast using the details provided below. An audio replay of the Meeting will also be available until October 24, 2020.

Webcast
https://produceredition.webcasts.com/starthere.jsp?ei=1348223&tp_key=493036b225 

Phone
North American toll-free dial-in: 888-390-0546
Confirmation #: 82714675

Replay Information
North American toll-free dial-in: 1-888-390-0541
Replay entry code: 714675 #

About Canopy Rivers Inc.
Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. We believe that bringing together people, capital, and ideas raises the potential of the entire cannabis industry. By leveraging our industry insights, in-house expertise, and thesis-driven approach to investing, we aim to provide Shareholders with exposure to specialized and disruptive cannabis companies. Our mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with our portfolio, we are helping build the cannabis industry of tomorrow, today.

Forward-Looking Statements
This news release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. 

Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding the date, time and location of, and the matters to be voted upon at, the Meeting and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; competition risks; changes in cannabis industry growth and trends; changes in the business activities, focus and plans of the Company and its investees and the timing associated therewith; stock market volatility; the Company's actual financial results and ability to manage its cash resources; changes in general economic, business and political conditions, including challenging global financial conditions and the impact of the COVID-19 pandemic; potential conflicts of interest; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in the Company's relationship with Canopy Growth Corporation and its investees; risks associated with the termination, renegotiation and enforcement of material contracts; credit, liquidity and additional financing risks; changes in applicable laws; compliance with extensive government regulation, including the Company's interpretation of such regulation; changes in the global sentiment towards, and public opinion of, the cannabis industry; divestiture risks; and the risk factors set out in the Company's annual information form dated June 2, 2020, filed with the Canadian securities regulators and available on the Company's profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

SOURCE Canopy Rivers Inc.


These press releases may also interest you

at 10:55
As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the...

at 10:30
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of 4.0% from 2024 to 2029 according to a new report by MarketsandMarketstm. Similarly, the vaccines...

at 10:25
The "Global High-Altitude Aeronautical Platform Station (HAAPS) Market: Focus on Type, Frequency Band, Subsystem, Application, End User, and Country - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The...

at 10:20
The "Airport Robots Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The airport robots market has grown rapidly in recent years. It will grow from $1.29 billion in 2023 to $1.5 billion in 2024 at a compound...

at 10:20
The "HbA1c Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)"...

at 10:20
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and Resilience...



News published on and distributed by: